Stockscreener 앱 받기
1.09
1.86%
0.02
전일 마감가:
$1.07
열려 있는:
$1.08
하루 거래량:
427.42K
Relative Volume:
0.27
시가총액:
$16.44M
수익:
-
순이익/손실:
$-11.90M
주가수익비율:
-0.00529
EPS:
-206.0125
순현금흐름:
$-12.75M
1주 성능:
+4.80%
1개월 성능:
+15.95%
6개월 성능:
-8.41%
1년 성능:
+73.69%
1일 변동 폭
$1.05
$1.10
1주일 범위
$0.9601
$1.10
52주 변동 폭
$0.1131
$3.95
Allarity Therapeutics Inc Stock (ALLR) Company Profile
명칭
Allarity Therapeutics Inc
전화
401-426-4664
주소
24 SCHOOL ST., 2ND FLOOR, BOSTON
ALLR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.09 | 15.38M | 0 | -11.90M | -12.75M | -206.01 |
|
ONC
Beigene Ltd Adr
|
236.72 | 25.21B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.42 | 110.94B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2632 | 40.72M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
606.50 | 62.15B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
74.64 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Allarity Therapeutics Inc 주식(ALLR)의 최신 뉴스
Allarity Therapeutics CEO to Present at Pharma Summit - TipRanks
Allarity Therapeutics Announces Participation in Pharma Partnering Summit US - GlobeNewswire
Metrics That Matter About Allarity Therapeutics Inc (NASDAQ: ALLR) - Stocksregister
Allarity Therapeutics Reports Positive Clinical Updates and Financial Highlights for Q1 2025 - Nasdaq
Allarity Therapeutics Provides First Quarter 2025 Update, - GlobeNewswire
Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment - Stock Titan
ALLR ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Allarity Therapeutics, Inc. - ACCESS Newswire
You might want to take a look at Allarity Therapeutics Inc (ALLR) now - Sete News
Was anything positive for Allarity Therapeutics Inc (ALLR) stock last session? - uspostnews.com
The Psychology of Allarity Therapeutics Inc Inc. (ALLR) Price Performance: Understanding Market Sentiment - investchronicle.com
Upward Trajectory: Allarity Therapeutics Inc (ALLR) Posts a Slidee, Closing at 1.07 - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Allarity unveils new multiple myeloma treatment predictor - Investing.com
Allarity unveils new multiple myeloma treatment predictor By Investing.com - Investing.com South Africa
Healthy Upside Potential: Allarity Therapeutics Inc (ALLR) - Sete News
Allarity Therapeutics Presents Novel Drug Response - GlobeNewswire
Novel AI Predictor Identifies Multiple Myeloma Patients for Targeted Treatment | ALLR Stock News - Stock Titan
Ratios Revealed: Decoding Allarity Therapeutics Inc (ALLR)’s Financial Health - DWinneX
How to interpret Allarity Therapeutics Inc (ALLR)’s stock chart patterns - uspostnews.com
Allarity Therapeutics Inc (ALLR) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Allarity Therapeutics Restructures Board of Directors - TipRanks
ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - PR Newswire
Allarity Therapeutics stock hits 52-week low at $0.67 - Investing.com
Allarity Therapeutics stock hits 52-week low at $0.67 By Investing.com - Investing.com Canada
There is no way Allarity Therapeutics Inc (ALLR) can keep these numbers up - Sete News
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire
Allarity Therapeutics Inc (ALLR) Is A Good Stock To Invest In - Stocksregister
Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Bright Minds Biosciences (NASDAQ:DRUG) - Defense World
ALLR Stockholders Have Opportunity to Lead Allarity Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert - Benzinga
XPeng, Ultralife And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Allarity Therapeutics, Inc. SEC 10-K Report - TradingView
Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update - GlobeNewswire
Allarity's Cancer Drug Shows 17-Month Benefit as Cash Runway Extends to 2027 - Stock Titan
Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Update - The AM Reporter
Allarity Therapeutics (NASDAQ:ALLR) Trading 11% Higher – Still a Buy? - Defense World
Allarity Therapeutics probes potential stock manipulation By Investing.com - Investing.com Australia
Allarity Therapeutics probes potential stock manipulation - Investing.com
Allarity Therapeutics Launches Comprehensive Effort to Combat Potential Illegal Naked Short Selling of Its Shares - GlobeNewswire
Allarity Therapeutics Inc (ALLR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.91%
자본화:
|
볼륨(24시간):